載入...
Omega‐3 fatty acids for dialysis vascular access outcomes in patients with chronic kidney disease
BACKGROUND: Maintaining long‐term vascular access patency is necessary for high quality haemodialysis (HD) treatment of patients with the terminal and most serious stage of chronic kidney disease (CKD) ‐ end‐stage kidney disease (ESKD). Oral supplementation with omega‐3 fatty acids (ω‐3FA) may help...
Na minha lista:
| 發表在: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley & Sons, Ltd
2018
|
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6517057/ https://ncbi.nlm.nih.gov/pubmed/30480758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011353.pub2 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|